DMK Pharmaceuticals is looking to explore strategic commercial or development opportunities in several neuro-therapeutic areas such as Opioid Use Disorder (OUD), urological diseases and Parkinson’s. We believe that developing and strengthening the science and accessibility in these areas is essential to providing better treatment for patients. Our ideal partners share our passion and dedication to saving lives.
Please contact us to talk with our Business Development team.
Want to learn more?
Read our press release go to our Investor Relations page or visit https://dmkpharma.com/
Check this page for the most recent updates regarding the merger process.